🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Compare the activity of 5 mg levocetirizine and 5 mg desloratadine on aller...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00521170
Treatments Being Tested
The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00866788
Treatments Being Tested
The purpose of this study is to compare the rate and extent of absorption o...
Status
Completed
Location
SFBC, Ft. Myers, Inc.,
Start Date
2005-12
Trial ID
NCT01314339
Treatments Being Tested
The primary objective of this study was to determine whether children ages ...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00780403
Treatments Being Tested
The aim of this study is to compare cold urticaria lesions by thermography,...
Status
Completed
Location
Allergie-Centrum-Charité Berlin
Start Date
2006-11
Trial ID
NCT00600847
Treatments Being Tested
This is an open label, randomised, single dose, 2-way crossover, comparativ...
Status
Completed
Location
SFBC Ft Myers Inc
Start Date
2006-01
Trial ID
NCT01506050
Treatments Being Tested
This is an open label, randomised, single dose, 2-way crossover, comparativ...
Status
Completed
Location
SFBC Ft Myers Inc
Start Date
2006-01
Trial ID
NCT01506037
Treatments Being Tested
To evaluate the efficacy of Autologous Whole Blood Therapy versus conventio...
Status
Not Yet Recruiting
Location
Faculty of Medicine, Cairo university
Start Date
2026-04-30
Trial ID
NCT07486583
Treatments Being Tested
The purpose of this study is to compare urticaria lesions (size, kinetics) ...
Status
Completed
Location
Allergie-Centrum-Charite
Start Date
2007-09
Trial ID
NCT00598611
Treatments Being Tested
This is an open-label, single-dose, randomized, three-period, two-treatment...
Status
Completed
Location
Pharma Medica Research Inc.
Start Date
2021-12-02
Trial ID
NCT05356143
Treatments Being Tested